Integrated development of nanobody-targeted AAVs for lower dose, improve efficacy and safety profile - just tell your target, we do the rest, from VHH discovery to GLP tox studies
CER Groupe is a ISO/GLP/Biobank-certified Research Center supporting vaccines and immunotherapy sector through comprehensive in vitro/in vivo bioproduction & non-clinical CRO services : Strong expertise in immunology Biobank certification to test products on PBMC or other tissue-specific primary cells (toxicity, activation, Immunomonitoring platform (sterile cell sorting, FluoroSpot, cytokine profiling (MSD), immunopeptidomics, gene expression, cell culture) In vivo multi-species (small/large animals) platform including expertise with humanized mice, immunodeficient models, in a SPF environment Infectiology capacities up to BSL-3 for challenge studies Catalog of mouse and human cancer cell lines for immuno-oncology Bioproduction platform for vaccine (protein, viral vector, VLP) and functional antibody development and characterization
Biologist specialized in biologics discovery, optimization, pre-GMP production, preclinical in vitro/vivo characterization and companion diagnostic dev (ADA,..)
Social media
Additional questions
How would you categorise yourself?
Business Developer
Organisation Type
Public / Non-Profit OrganisationVaccine/Immunotherapy ManufacturerContract Research Organizations (CRO)
Areas of expertise
Research and developmentPreclinical research Immunotherapy developmentCell and Gene therapyVaccine development DiagnosticsManufacturing and productionBioprocessing and biomanufacturing